8/7/2019 drug study acis

1/3

GENERIC

NAME

DOSAGE/

FREQUENCY

CLASSIFICATION INDICATIONS CONTRAINDICATION

S

SIDE EFFECT(S) NSG.

RESPONSIBILITIES

Carvedilol 3.125 mg BID for 2weeks may be

increased to 6.25

mg BID. Double

dose every 2 weeks

to the highest

tolerated by the

patient.

Beta-blocker treatment of mildto

moderate congest

ive heart

failure (CHF).

2nd

or 3rd

degreeheart block, severely

bradychardia, shock,

uncontrolled heart

failure, asthma.

The most commonside effects are

dizziness, fatigue,

hypotension,

diarrhea, asthenia,

bradychardia, and

weight gain.

Monitor for use ofother similar

acting drugs eg:

alcohol.

Monitor vital

signs, assess for

risk factors.

Instruct client not

to take a doubledose if they miss a

dose.

Warn not to stop

the medication

suddenly due to

the rsik of

rebound

hypertension.Ramipril HTN: initial dose

1.25 mg OD. CHF:

initially 1.25 mg

OD. MI: 2.5 mg BID.

Maintenance dose:

10 mg OD.

ACE inhibitor Treatment of CHF,

HTN/HPN, MI.

Aortic stenosis or

outflow tract

obstruction,

pregnancy.

may cause swelling

of the mouth,

tongue, or throat

low blood sugar in

patients taking

other medicine for

diabetes which

shows as sweatingor shakiness

Dry cough may

develop, dizziness,

and light-

headedness due to

low blood pressure.

(It is recommended

Monitor for use of

other similar

acting drugs eg:

alcohol.

Monitor vital

signs, assess for

risk factors.

Instruct client notto take a double

dose if they miss a

dose.

Warn not to stop

the medication

suddenly due to

the rsik of

8/7/2019 drug study acis

2/3

to start treatment

with the lowest

dose.)decreased sex drive

tiredness and

fatigue especially in

the early stages

mouth dryness in

the early stages

rebound

hypertension.

Clopidogrel 1 tablet OD Anticoagulant,

antiplatelet,fibronolytic

(thrombolytic)

used to inhibit

blood clotsincoronary artery

disease, periphera

l vascular disease,

and cerebrovascul

ar disease.

Active pathological

bleeding

Severe neutropenia

(low white bloodcells)

Thrombotic

thrombocytopenic

purpura (TTP)

Hemorrhage - The

annual incidence of

hemorrhage may

be increased by theco-administration

of aspirin.

Monitor for

bleeding.Monitor

coagulation ratios

(INR's).

Implement

appropriate safety

measures to

prevent bleeding

ISMN

(Isosorbide

Mononitrate

)

1 cap/tab OD Anti-anginal Treatment for

angina pectoris

Hypersensitivity to

nitrate compounds.

Uncompensated

cardiac failure,

cardigenic shock,

marked bradycardia.

Headache

necessitating

withdrawal

Tiredness, sleep

disturbances and

gastrointestinaldisturbances

Asses location,

duration, intensity

of anginal pain.

Assess vital signs

regularily.

Monitor forhypotension

Simvastatin Initially 10 mg once

daily. Max: 40 mg

once daily

Dyslipidaemic

agent

Treatment of

hypercholesterole

mias

Abdominal pain,

diarrhea, indigestion,

and a general feeling

of weakness.

Active liver disease

or unexplained

persistent

elevations of serum

transaminases.

Pregnancy and

Assess nutrition:

fat, protein,

carbohydrates

Monitor bowel

pattern daily

Monitor

8/7/2019 drug study acis

3/3

lactation. triglycerides,

cholesterol

baselinethroughout

treatment